Health & Wellness Treatments At Their Lowest Prices.

✦ Licensed US Providers✦ Free Discreet Shipping✦ No Insurance Needed✦ No Dosage-Based Price Increases✦ No Hidden Fees✦ Licensed US Providers✦ Free Discreet Shipping✦ No Insurance Needed✦ No Dosage-Based Price Increases✦ No Hidden Fees

Important Safety Information

Zepbound (Tirzepatide)

Prescription Medication

Zepbound (tirzepatide) is an FDA-approved once-weekly injection for chronic weight management in adults. As a dual GIP/GLP-1 receptor agonist, it addresses two hormone pathways to deliver superior weight reduction in clinical trials. A valid prescription and ongoing provider supervision are required.

Emergency: If you experience chest pain, severe shortness of breath, a prolonged painful erection (over 4 hours), or sudden vision/hearing loss — call 911 or go to your nearest emergency room immediately.

Who Should Not Use Zepbound (Tirzepatide)

  • Personal or family history of MTC or MEN 2
  • Known hypersensitivity to tirzepatide
  • Pregnant or breastfeeding individuals
  • Patients with active gallbladder disease or severe GI disease

Warnings & Precautions

Thyroid Tumors

Contraindicated in patients with a personal or family history of MTC or MEN 2 syndrome. Counsel patients to report neck masses, dysphagia, or persistent hoarseness.

Acute Pancreatitis

Discontinue immediately upon suspicion of pancreatitis. Reassess before restarting therapy.

Gallbladder Disease

Rapid weight loss associated with tirzepatide may increase risk of gallstone formation. Report right-sided abdominal pain, nausea, or fever promptly.

Heart Rate

Modest increases in resting heart rate have been observed. Monitor patients with underlying cardiac conditions.

Common Side Effects

This is not a complete list. Contact your provider if you experience any concerning symptoms.

  • Nausea and vomiting
  • Diarrhea
  • Constipation
  • Abdominal pain or discomfort
  • Decreased appetite
  • Injection site reactions
  • Headache

Drug Interactions

Always inform your provider of all medications, supplements, and substances you are currently taking.

  • Insulin and sulfonylureas — increase hypoglycemia risk
  • Oral drugs sensitive to gastric emptying rate
  • Other incretin-based therapies — do not combine

When to Contact Your Provider

  • Suspected pancreatitis
  • Gallbladder symptoms
  • Signs of thyroid tumors
  • Hypoglycemia events
  • Severe dehydration from persistent vomiting or diarrhea

This safety information is provided for general educational purposes only and does not constitute medical advice. It is not a substitute for the full prescribing information, package insert, or guidance from your licensed healthcare provider. Individual responses to medications and supplements vary. MEDVera providers review your complete health profile before recommending or prescribing any treatment.

Call Us(877) 353-GLP1 (4571)(877) 353-GLP1 (4571)